scholarly journals Effect of Cortex Lycii Radicis Ethanol-Extract on the Hypoglycemic and Hypolipidemic In Type 2 Diabetic Rats

Author(s):  
Changlei Li ◽  
Xiji Shu ◽  
Xiaoqing Chen ◽  
Yuwei Liu ◽  
Huiling Yi ◽  
...  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Zhan-Zhong Liu ◽  
Qing-Hua Liu ◽  
Zhao Liu ◽  
Jia-Wei Tang ◽  
Eng-Guan Chua ◽  
...  

Abstract Background Mulberry leaf as a traditional Chinese medicine is able to treat obesity, diabetes, and dyslipidemia. It is well known that diabetes leads to intestinal microbiota dysbiosis. It is also recently discovered that liver glycogen structure is impaired in diabetic animals. Since mulberry leaves are able to improve the diabetic conditions through reducing blood glucose level, it would be interesting to investigate whether they have any positive effects on intestinal microbiota and liver glycogen structure. Methods In this study, we first determined the bioactive components of ethanol extract of mulberry leaves via high-performance liquid chromatography (HPLC) and liquid chromatography/mass spectrometry (LC/MS). Murine animal models were divided into three groups, normal Sprague-Dawley (SD) rats, high-fat diet (HFD) and streptozotocin (STZ) induced type 2 diabetic rats, and HFD/STZ-induced rats administered with ethanol extract of mulberry leaves (200 mg/kg/day). Composition of intestinal microbiota was analyzed via metagenomics by sequencing the V3-V4 region of 16S rDNAs. Liver glycogen structure was characterized through size exclusion chromatography (SEC). Both Student’s t-test and Tukey’s test were used for statistical analysis. Results A group of type 2 diabetic rat models were successfully established. Intestinal microbiota analysis showed that ethanol extract of mulberry leaves could partially change intestinal microbiota back to normal conditions. In addition, liver glycogen was restored from fragile state to stable state through administration of ethanol extract of mulberry leaves. Conclusions This study confirms that the ethanol extract of mulberry leaves (MLE) ameliorates intestinal microbiota dysbiosis and strengthens liver glycogen fragility in diabetic rats. These finding can be helpful in discovering the novel therapeutic targets with the help of further investigations.


1970 ◽  
Vol 19 (2) ◽  
pp. 157-164 ◽  
Author(s):  
Zaied Ahmed Bhuyan ◽  
Begum Rokeya ◽  
Nuruzzaman Masum ◽  
Shahdat Hossain ◽  
Ishtiaq Mahmud

The present study evaluates the effects of powder and ethanol extract of Syzygium cumini seeds (1.25/ kg bw) treatment for 21 days on glucose homeostasis, serum insulin, serum lipids and liver glycogen content in streptozotocin (STZ) induced type 2 diabetic rats. The administration of S. cumini seed powder and ethanol extract for 21 days to type 2 diabetic rats significantly reduced the fasting glucose level although it did not alter the blood glucose level after glucose challenge. The insulin level and liver glycogen content also were not changed after dietary administration of Syzygium cumin powder or ethanol extract. In addition to hypoglycemic effect, the Syzygium cumini significantly ameliorated the lipid profile. The plasma LDL?cholesterol level, an atherogenic lipid, significantly (p < 0.01) decreased with a concurrent increase (p < 0.01) in the plasma HDL?cholesterol level, thus suggesting dietary Syzygium cumini could be used as one of the alternatives in the treatment of diabetes.    Key words: Syzygium cumini; Diabetes; Cholesterol DOI: http://dx.doi.org/10.3329/dujbs.v19i2.8959 DUJBS 2010; 19(2): 157-164


2013 ◽  
Vol 2013 ◽  
pp. 1-8 ◽  
Author(s):  
Kok Keong Tan ◽  
Kah Hwi Kim

The antidiabetic potential ofAlternanthera sessilisRed was investigated using the obese type 2 diabetic rats induced by high fat diet and streptozotocin. Three fractions (hexane, ethyl acetate, and water) were obtained from the crude ethanol extract ofAlternanthera sessilisRed.Alternanthera sessilisRed ethyl acetate fraction (ASEAF) was found to possess the most potent antihyperglycemic effect through oral glucose tolerance test. The ASEAF was subsequently given to the diabetic rats for two weeks. It was found that two-week administration of ASEAF reduces the fasting blood glucose level, triglyceride level, and free fatty acid level of the rats. ASEAF-treated diabetic rats showed higher pancreatic insulin content and pancreatic total superoxide dismutase activity compared to the untreated diabetic rats. Also, the insulin sensitivity indexes suggested that ASEAF ameliorates the insulin resistant state of the diabetic rats. In conclusion, ASEAF could be developed into a potential antidiabetic agent for the management of type 2 diabetes.


Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 643-P ◽  
Author(s):  
YANFEI HAN ◽  
LINDONG LI ◽  
YANJUN LIU ◽  
YOU WANG ◽  
CHUNHUA YAN ◽  
...  

2010 ◽  
Vol 8 (4) ◽  
pp. 293-297 ◽  
Author(s):  
Teng GUAN ◽  
Yi-Song QIAN ◽  
Meng-Hao HUANG ◽  
Long-Fei HUANG ◽  
Xu-Zhen TANG ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document